SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-064639
Filing Date
2023-11-17
Accepted
2023-11-17 06:02:56
Documents
12
Period of Report
2023-11-14
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K idya-20231114.htm   iXBRL 8-K 43537
  Complete submission text file 0000950170-23-064639.txt   165184

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT idya-20231114_pre.xml EX-101.PRE 11427
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT idya-20231114_lab.xml EX-101.LAB 13904
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT idya-20231114.xsd EX-101.SCH 2467
6 EXTRACTED XBRL INSTANCE DOCUMENT idya-20231114_htm.xml XML 4901
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38915 | Film No.: 231416345
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences